Advertisement

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

Timothy Hughes, Michael Deininger, Andreas Hochhaus, Susan Branford, Jerald Radich, Jaspal Kaeda, Michele Baccarani, Jorge Cortes, Nicholas C. P. Cross, Brian J. Druker, Jean Gabert, David Grimwade, Rüdiger Hehlmann, Suzanne Kamel-Reid, Jeffrey H. Lipton, Janina Longtine, Giovanni Martinelli, Giuseppe Saglio, Simona Soverini, Wendy Stock and John M. Goldman

Article Information

Citation 
vol. 108 no. 1 28-37
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted January 10, 2006
  • Accepted February 18, 2006
  • Published online June 21, 2006.


Contributors 
  • Timothy Hughes
  • Michael Deininger
  • Andreas Hochhaus
  • Susan Branford
  • Jerald Radich
  • Jaspal Kaeda
  • Michele Baccarani
  • Jorge Cortes
  • Nicholas C. P. Cross
  • Brian J. Druker
  • Jean Gabert
  • David Grimwade
  • Rüdiger Hehlmann
  • Suzanne Kamel-Reid
  • Jeffrey H. Lipton
  • Janina Longtine
  • Giovanni Martinelli
  • Giuseppe Saglio
  • Simona Soverini
  • Wendy Stock
  • John M. Goldman

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output